RE: Order filling3 Jan 2025 10:24
Jaari888
Your question was addressed 3 weeks ago
Both FAB PYC
1 generating large revenues relatove to market cap FAB half year £1.2mln half year v £5mln cap , PYC £1mln half year V £1.4mln
2 Both have cash
3 forefront of AI improving drug discovery
4 good, honest BODs
5 near to profitability in 2025
6 benefitting from UK grant funding
7 tiny market caps ( £5mln and £.14mln) versus peers on AIM